Inventor · disambiguated record
Steven Norman Quayle
Also filed as: QUAYLE STEVEN · QUAYLE STEVEN N · QUAYLE STEVEN NORMAN
11 granted patents·6 pending applications·12 citations·filing 2014–2022
84Inventor score
Top patents by PatentIndex Score
17 records- 0185US11337975B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2017·Granted May 24, 2022·2 cites·5 claims
- 0281US11324744B2Methods of use and pharmaceutical combinations of histone deacetylase inhibitors and CD20 inhibitory antibodiesACETYLON PHARMACEUTICALS INC·Filed 2017·Granted May 10, 2022·2 cites·13 claims
- 0380US11298354B2Methods of use and pharmaceutical combinations of HDAC inhibitors with BET inhibitorsDANA FARBER CANCER INST INC·Filed 2017·Granted Apr 12, 2022·2 cites·11 claims
- 0476US11357776B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and an aurora kinase inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Jun 14, 2022·2 cites·4 claims
- 0576US11311540B2Increasing expression of interferon regulated genes with combinations of histone deacetylase inhibitors and immunomodulatory drugsACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Apr 26, 2022·2 cites·7 claims
- 0673US12053468B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2022·Granted Aug 6, 2024·0 cites·14 claims
- 0772US9949972B2Combinations of histone deacetylase inhibitors and immunomodulatory drugsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Apr 24, 2018·2 cites·7 claims
- 0871US11872227B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and an aurora kinase inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2022·Granted Jan 16, 2024·0 cites·4 claims
- 0969US2023190744A1Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (pd-l1) inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1066US2020323849A1Combinations of histone deacetylase inhibitors and immunomodulatory drugsACETYLON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1163US11497746B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Nov 15, 2022·0 cites·3 claims
- 1258US2022288066A1Increasing expression of interferon regulated genes with combinatons of histone deacetylase inhibitors and immunomodulatory drugsACETYLON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1357US2015105358A1Combinations of histone deacetylase inhibitors and immunomodulatory drugsQUAYLE STEVEN NORMAN·Filed 2014·Application pending·0 cites
- 1446US11998546B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and epothilone and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Jun 4, 2024·0 cites·7 claims
- 1543US2015105383A1HDAC Inhibitors, Alone Or In Combination With PI3K Inhibitors, For Treating Non-Hodgkin's LymphomaQUAYLE STEVEN NORMAN·Filed 2014·Application pending·0 cites
- 1638US2015105409A1Hdac inhibitors, alone or in combination with btk inhibitors, for treating nonhodgkin's lymphomaQUAYLE STEVEN NORMAN·Filed 2014·Application pending·0 cites
- 1736US11813261B2HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic lymphocytic leukemiaACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Nov 14, 2023·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Steven Norman Quayle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →